Impact of Cannabinoids on Sleep Parameters in Patients Undergoing Sleep Studies

Overview

About this study

The overarching purpose of this study is to advance our understanding of how cannabinoids interact with sleep physiology, potentially offering insights into their therapeutic or detrimental roles in sleep disorders. By elucidating the specific effects of cannabinoids on different aspects of sleep, this research could inform clinical practices and guide the development of cannabinoid-based interventions for sleep-related issues.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 18 years or older.
  • Undergoing Sleep Study at Mayo Clinic Florida OR Home Sleep study.
  • Able to provide consent.

Exclusion Criteria: 

  • Inability to provide consent.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 9/4/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Mohit Chauhan, M.B.B.S.

Open for enrollment

Contact information:

Aubri Wooten

Wooten.Aubri@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20578709

Mayo Clinic Footer